1. Home
  2. BRC vs LQDA Comparison

BRC vs LQDA Comparison

Compare BRC & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brady Corporation

BRC

Brady Corporation

HOLD

Current Price

$91.82

Market Cap

3.7B

ML Signal

HOLD

LQDA

Liquidia Corporation

HOLD

Current Price

$30.59

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRC
LQDA
Founded
1914
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.1B
IPO Year
2005
2020

Fundamental Metrics

Financial Performance
Metric
BRC
LQDA
Price
$91.82
$30.59
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
$38.60
AVG Volume (30 Days)
240.9K
1.8M
Earning Date
05-20-2026
01-01-0001
Dividend Yield
1.07%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,144,698,000.00
$13,996,000.00
Revenue This Year
$6.90
$993.31
Revenue Next Year
$3.83
$219.14
P/E Ratio
$23.35
N/A
Revenue Growth
5.86
N/A
52 Week Low
$62.70
$11.26
52 Week High
$99.29
$46.67

Technical Indicators

Market Signals
Indicator
BRC
LQDA
Relative Strength Index (RSI) 56.28 33.46
Support Level $75.38 $21.56
Resistance Level $99.29 $36.07
Average True Range (ATR) 3.47 2.65
MACD -0.58 -1.23
Stochastic Oscillator 42.98 11.10

Price Performance

Historical Comparison
BRC
LQDA

About BRC Brady Corporation

Brady Corp provides identification solutions and workplace safety products. The company offers identification and healthcare products that are sold under the Brady brand to maintenance, repair, and operations as well as original equipment manufacturing customers. Products include safety signs and labeling systems, material identification systems, wire identification, patient identification, and people identification. Brady also provides workplace safety and compliance products such as safety and compliance signs, asset tracking labels, and first-aid products. The company is organized and managed on a geographic basis with two reportable segments: Americas & Asia which derives maximum revenue, and Europe & Australia.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: